Palouse Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Palouse Capital Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $19,192 - $21,760	400 New	400 $21,000
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $5.57 Million - $6.68 Million	-90,553 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $291,318 - $339,608	-5,432 Reduced 5.66%	90,553 $5.65 Million
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $143,901 - $168,561	-2,432 Reduced 2.47%	95,985 $5.68 Million
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $24,702 - $26,900	-399 Reduced 0.4%	98,417 $6.58 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $2.01 Million - $2.26 Million	33,847 Added 52.1%	98,816 $6.24 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $410,473 - $465,141	-7,109 Reduced 9.86%	64,969 $4.03 Million
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $891,945 - $988,392	-15,531 Reduced 17.73%	72,078 $4.35 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $178,822 - $209,061	-3,262 Reduced 3.59%	87,609 $5.15 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $172,051 - $250,030	-3,708 Reduced 3.92%	90,871 $5.07 Million
Q4 2019 Feb 07, 2020	SELL	$49.21 - $64.19 $294,472 - $384,112	-5,984 Reduced 5.95%	94,579 $6.07 Million
Q3 2019 Oct 31, 2019	BUY	$42.77 - $50.71 $4.3 Million - $5.1 Million	100,563 New	100,563 $5.1 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Palouse Capital Management, Inc. with notifications on news.